Drugmaker Pfizer Inc. agreed to pay a total of $785 million to resolve allegations that one of its companies didn't give Medicaid the same discounts it provided to private purchasers of the heartburn treatment Protonix.
Carmel-based Mainstreet Property Group is suing the Indiana State Department of Health in a legal challenge to the state’s new moratorium on nursing homes and transitional care properties.
CNO Financial Group Inc. on Wednesday reported quarterly results that fell short of Wall Street predictions.
Seven insurers, including Indianapolis-based Anthem Inc., reached an agreement with New York Attorney General Eric Schneiderman to cover hepatitis C drugs for patients in the early stages of the disease and for drug and alcohol users.
The company, which is in the process of buying rival insurer Cigna Corp. for $54 billion, said medical enrollment has climbed by about 1 million members since the end of 2015, reaching 39.6 million members.
Lilly got a boost from a stable of new drugs but saw sales tumble for longtime stalwarts Cymbalta and Humalog. Meanwhile, R&D costs rose as the company ushered products through its late-stage pipeline.
Shortages of workers and investment dollars remain the two biggest challenges for Indiana’s life sciences industry, which otherwise is showing robust vital signs and embarking on high-profile collaborations.
Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.
UnitedHealth Group Inc., the biggest U.S. health insurer, said it expects to lose about $650 million on the Obamacare plans this year.
On July 1, Indiana will join 46 states in allowing physicians to write prescriptions after talking to patients on their laptops or smartphones, with no office visit required.
The Carmel-based company has a hired a president and promoted longtime exec Erik Helding to chief financial officer. The company also announced the departure of its chief business officer.
The nation’s biggest health insurer has decided to stop selling coverage on public insurance exchanges in two states next year and is continuing to evaluate its presence in other markets after reporting steep losses.
A Medicare proposal to test new ways of paying for chemotherapy and other drugs given in a doctor's office has sparked a furious battle, and cancer doctors are demanding that the Obama administration scrap the experiment.
Dr. Joseph Tector, who built IU Health’s transplant program into one of the nation’s largest before announcing his departure Friday, is seeking back wages and penalties worth $4.7 million from the hospital system.
Indiana University Health’s Joseph Tector, who built the transplant program into one of the nation’s largest, has resigned after 15 years to take a job at the University of Alabama in Birmingham.
The three drugmakers that dominate the world diabetes market—Eli Lilly and Co., Novo Nordisk A/S and Sanofi—are introducing improved forms of insulin, with a price tag to match.
The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland—on paper—to reduce its tax bill.
Starting in July 2017, all coaches for every public school sport offered to students in grades five through 12 must complete a course on how to spot symptoms of concussions.
Several central Indiana groups already have received millions of dollars from Skill UP to give students and workers the training they need to fill jobs that are in high demand.
A small manufacturer angling to pick up more business in Indiana makes cold and allergy medicine resistant to being abused by methamphetamine makers.
